The store will not work correctly when cookies are disabled.
N'-Benzoyl-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
ID: ALA3309661
PubChem CID: 102143274
Max Phase: Preclinical
Molecular Formula: C16H14N4O2
Molecular Weight: 294.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2ccccn2c1C(=O)NNC(=O)c1ccccc1
Standard InChI: InChI=1S/C16H14N4O2/c1-11-14(20-10-6-5-9-13(20)17-11)16(22)19-18-15(21)12-7-3-2-4-8-12/h2-10H,1H3,(H,18,21)(H,19,22)
Standard InChI Key: DDFUNKDWXXFOOC-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
3.9422 -1.3004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1172 -1.3004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7047 -2.0149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1172 -2.7294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9422 -2.7294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3547 -2.0149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4942 -0.6874 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2479 -1.0229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1617 -1.8434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7748 -2.3954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6032 -3.2024 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5717 -2.1819 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1550 -2.7653 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9624 -0.6104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9519 -2.5517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1654 -1.7548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5821 -1.1715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7956 -0.3746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5925 -0.1611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1758 -0.7444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9623 -1.5413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5353 -3.1351 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 1 0
7 8 1 0
8 9 2 0
6 9 1 0
1 7 2 0
12 13 1 0
10 11 2 0
10 12 1 0
9 10 1 0
8 14 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
16 21 2 0
15 22 2 0
13 15 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.31 | Molecular Weight (Monoisotopic): 294.1117 | AlogP: 1.72 | #Rotatable Bonds: 2 |
Polar Surface Area: 75.50 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.80 | CX Basic pKa: 4.38 | CX LogP: 0.93 | CX LogD: 0.92 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.71 | Np Likeness Score: -2.08 |
References
1. Samala G, Nallangi R, Devi PB, Saxena S, Yadav R, Sridevi JP, Yogeeswari P, Sriram D.. (2014) Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors., 22 (15): [PMID:24953948] [10.1016/j.bmc.2014.05.038] |